nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—PTGS1—Sulfasalazine—ankylosing spondylitis	0.113	0.143	CbGbCtD
Ifosfamide—CYP2A6—Prednisolone—ankylosing spondylitis	0.112	0.141	CbGbCtD
Ifosfamide—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0677	0.0855	CbGbCtD
Ifosfamide—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0659	0.0832	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0451	0.0569	CbGbCtD
Ifosfamide—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0451	0.0569	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—ankylosing spondylitis	0.0437	0.0552	CbGbCtD
Ifosfamide—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0429	0.0542	CbGbCtD
Ifosfamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0348	0.044	CbGbCtD
Ifosfamide—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0338	0.0427	CbGbCtD
Ifosfamide—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0325	0.041	CbGbCtD
Ifosfamide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0273	0.0344	CbGbCtD
Ifosfamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0264	0.0334	CbGbCtD
Ifosfamide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0227	0.0286	CbGbCtD
Ifosfamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0227	0.0286	CbGbCtD
Ifosfamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0224	0.0282	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0211	0.0267	CbGbCtD
Ifosfamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0132	0.0166	CbGbCtD
Ifosfamide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000263	0.00126	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000262	0.00126	CcSEcCtD
Ifosfamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00026	0.00125	CcSEcCtD
Ifosfamide—Pneumonia—Methotrexate—ankylosing spondylitis	0.000259	0.00125	CcSEcCtD
Ifosfamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000259	0.00125	CcSEcCtD
Ifosfamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000259	0.00125	CcSEcCtD
Ifosfamide—Eye disorder—Prednisone—ankylosing spondylitis	0.000259	0.00124	CcSEcCtD
Ifosfamide—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000258	0.00124	CcSEcCtD
Ifosfamide—Infestation—Methotrexate—ankylosing spondylitis	0.000258	0.00124	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000258	0.00124	CcSEcCtD
Ifosfamide—Flushing—Prednisone—ankylosing spondylitis	0.000257	0.00123	CcSEcCtD
Ifosfamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000257	0.00123	CcSEcCtD
Ifosfamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000257	0.00123	CcSEcCtD
Ifosfamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.000257	0.00123	CcSEcCtD
Ifosfamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000256	0.00123	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000256	0.00123	CcSEcCtD
Ifosfamide—Renal failure—Methotrexate—ankylosing spondylitis	0.000254	0.00122	CcSEcCtD
Ifosfamide—Angioedema—Dexamethasone—ankylosing spondylitis	0.000253	0.00122	CcSEcCtD
Ifosfamide—Angioedema—Betamethasone—ankylosing spondylitis	0.000253	0.00122	CcSEcCtD
Ifosfamide—Stomatitis—Methotrexate—ankylosing spondylitis	0.000251	0.00121	CcSEcCtD
Ifosfamide—Angiopathy—Prednisone—ankylosing spondylitis	0.000251	0.00121	CcSEcCtD
Ifosfamide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000251	0.0012	CcSEcCtD
Ifosfamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000251	0.0012	CcSEcCtD
Ifosfamide—Immune system disorder—Prednisone—ankylosing spondylitis	0.00025	0.0012	CcSEcCtD
Ifosfamide—Malaise—Betamethasone—ankylosing spondylitis	0.00025	0.0012	CcSEcCtD
Ifosfamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00025	0.0012	CcSEcCtD
Ifosfamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000249	0.0012	CcSEcCtD
Ifosfamide—Oedema—Triamcinolone—ankylosing spondylitis	0.000249	0.0012	CcSEcCtD
Ifosfamide—Vertigo—Betamethasone—ankylosing spondylitis	0.000249	0.00119	CcSEcCtD
Ifosfamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000249	0.00119	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000249	0.00119	CcSEcCtD
Ifosfamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000248	0.00119	CcSEcCtD
Ifosfamide—Infection—Triamcinolone—ankylosing spondylitis	0.000248	0.00119	CcSEcCtD
Ifosfamide—Infection—Methylprednisolone—ankylosing spondylitis	0.000247	0.00119	CcSEcCtD
Ifosfamide—Haematuria—Methotrexate—ankylosing spondylitis	0.000246	0.00118	CcSEcCtD
Ifosfamide—Alopecia—Prednisone—ankylosing spondylitis	0.000245	0.00118	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000244	0.00117	CcSEcCtD
Ifosfamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000244	0.00117	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000243	0.00117	CcSEcCtD
Ifosfamide—Mental disorder—Prednisone—ankylosing spondylitis	0.000243	0.00117	CcSEcCtD
Ifosfamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000241	0.00116	CcSEcCtD
Ifosfamide—Malnutrition—Prednisone—ankylosing spondylitis	0.000241	0.00116	CcSEcCtD
Ifosfamide—Erythema—Prednisone—ankylosing spondylitis	0.000241	0.00116	CcSEcCtD
Ifosfamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000241	0.00116	CcSEcCtD
Ifosfamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000241	0.00116	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00024	0.00115	CcSEcCtD
Ifosfamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00024	0.00115	CcSEcCtD
Ifosfamide—Convulsion—Betamethasone—ankylosing spondylitis	0.00024	0.00115	CcSEcCtD
Ifosfamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000239	0.00115	CcSEcCtD
Ifosfamide—Hypertension—Betamethasone—ankylosing spondylitis	0.000239	0.00115	CcSEcCtD
Ifosfamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000236	0.00113	CcSEcCtD
Ifosfamide—Myalgia—Betamethasone—ankylosing spondylitis	0.000236	0.00113	CcSEcCtD
Ifosfamide—Discomfort—Betamethasone—ankylosing spondylitis	0.000233	0.00112	CcSEcCtD
Ifosfamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000233	0.00112	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000233	0.00112	CcSEcCtD
Ifosfamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000232	0.00112	CcSEcCtD
Ifosfamide—Pain—Prednisolone—ankylosing spondylitis	0.000232	0.00111	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000232	0.00111	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000232	0.00111	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000229	0.0011	CcSEcCtD
Ifosfamide—Vision blurred—Prednisone—ankylosing spondylitis	0.000227	0.00109	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000227	0.00109	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000227	0.00109	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000227	0.00109	CcSEcCtD
Ifosfamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000226	0.00109	CcSEcCtD
Ifosfamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000226	0.00109	CcSEcCtD
Ifosfamide—Oedema—Dexamethasone—ankylosing spondylitis	0.000226	0.00109	CcSEcCtD
Ifosfamide—Oedema—Betamethasone—ankylosing spondylitis	0.000226	0.00109	CcSEcCtD
Ifosfamide—Infection—Betamethasone—ankylosing spondylitis	0.000225	0.00108	CcSEcCtD
Ifosfamide—Infection—Dexamethasone—ankylosing spondylitis	0.000225	0.00108	CcSEcCtD
Ifosfamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000224	0.00107	CcSEcCtD
Ifosfamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000224	0.00107	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000223	0.00107	CcSEcCtD
Ifosfamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000223	0.00107	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000223	0.00107	CcSEcCtD
Ifosfamide—Anaemia—Prednisone—ankylosing spondylitis	0.000223	0.00107	CcSEcCtD
Ifosfamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000222	0.00107	CcSEcCtD
Ifosfamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000222	0.00106	CcSEcCtD
Ifosfamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000222	0.00106	CcSEcCtD
Ifosfamide—Agitation—Prednisone—ankylosing spondylitis	0.000222	0.00106	CcSEcCtD
Ifosfamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000221	0.00106	CcSEcCtD
Ifosfamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000221	0.00106	CcSEcCtD
Ifosfamide—Angioedema—Prednisone—ankylosing spondylitis	0.00022	0.00106	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000219	0.00105	CcSEcCtD
Ifosfamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000219	0.00105	CcSEcCtD
Ifosfamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000219	0.00105	CcSEcCtD
Ifosfamide—Malaise—Prednisone—ankylosing spondylitis	0.000218	0.00104	CcSEcCtD
Ifosfamide—Vertigo—Prednisone—ankylosing spondylitis	0.000217	0.00104	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000216	0.00104	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.000216	0.00104	CcSEcCtD
Ifosfamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000216	0.00103	CcSEcCtD
Ifosfamide—Anorexia—Betamethasone—ankylosing spondylitis	0.000216	0.00103	CcSEcCtD
Ifosfamide—Urticaria—Prednisolone—ankylosing spondylitis	0.000215	0.00103	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000215	0.00103	CcSEcCtD
Ifosfamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000215	0.00103	CcSEcCtD
Ifosfamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000214	0.00103	CcSEcCtD
Ifosfamide—Pain—Triamcinolone—ankylosing spondylitis	0.000213	0.00102	CcSEcCtD
Ifosfamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000211	0.00101	CcSEcCtD
Ifosfamide—Hypotension—Betamethasone—ankylosing spondylitis	0.000211	0.00101	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—ankylosing spondylitis	0.00021	0.00101	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000209	0.001	CcSEcCtD
Ifosfamide—Convulsion—Prednisone—ankylosing spondylitis	0.000209	0.001	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000209	0.001	CcSEcCtD
Ifosfamide—Hypertension—Prednisone—ankylosing spondylitis	0.000208	0.001	CcSEcCtD
Ifosfamide—Chills—Methotrexate—ankylosing spondylitis	0.000208	0.000998	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000206	0.000989	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000206	0.000989	CcSEcCtD
Ifosfamide—Arthralgia—Prednisone—ankylosing spondylitis	0.000205	0.000986	CcSEcCtD
Ifosfamide—Myalgia—Prednisone—ankylosing spondylitis	0.000205	0.000986	CcSEcCtD
Ifosfamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000205	0.000986	CcSEcCtD
Ifosfamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000205	0.000984	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—ankylosing spondylitis	0.000205	0.000983	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000204	0.000979	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000203	0.000976	CcSEcCtD
Ifosfamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000203	0.000975	CcSEcCtD
Ifosfamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000203	0.000975	CcSEcCtD
Ifosfamide—Discomfort—Prednisone—ankylosing spondylitis	0.000203	0.000974	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000203	0.000974	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000202	0.000968	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—ankylosing spondylitis	0.000202	0.000968	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0002	0.000958	CcSEcCtD
Ifosfamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000198	0.00095	CcSEcCtD
Ifosfamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000197	0.000948	CcSEcCtD
Ifosfamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000197	0.000946	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000197	0.000945	CcSEcCtD
Ifosfamide—Oedema—Prednisone—ankylosing spondylitis	0.000197	0.000945	CcSEcCtD
Ifosfamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000197	0.000944	CcSEcCtD
Ifosfamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000197	0.000944	CcSEcCtD
Ifosfamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000197	0.000944	CcSEcCtD
Ifosfamide—Infection—Prednisone—ankylosing spondylitis	0.000196	0.000939	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000195	0.000937	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000195	0.000937	CcSEcCtD
Ifosfamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000195	0.000936	CcSEcCtD
Ifosfamide—Fatigue—Betamethasone—ankylosing spondylitis	0.000195	0.000936	CcSEcCtD
Ifosfamide—Pain—Dexamethasone—ankylosing spondylitis	0.000193	0.000928	CcSEcCtD
Ifosfamide—Pain—Betamethasone—ankylosing spondylitis	0.000193	0.000928	CcSEcCtD
Ifosfamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000193	0.000927	CcSEcCtD
Ifosfamide—Skin disorder—Prednisone—ankylosing spondylitis	0.000191	0.000918	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00019	0.000914	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00019	0.000912	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—ankylosing spondylitis	0.000188	0.000901	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000187	0.000898	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—ankylosing spondylitis	0.000186	0.000895	CcSEcCtD
Ifosfamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000186	0.000894	CcSEcCtD
Ifosfamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000186	0.000894	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000185	0.000888	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000185	0.000888	CcSEcCtD
Ifosfamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000184	0.000881	CcSEcCtD
Ifosfamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000183	0.000879	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—ankylosing spondylitis	0.000182	0.000873	CcSEcCtD
Ifosfamide—Vertigo—Methotrexate—ankylosing spondylitis	0.000181	0.00087	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00018	0.000866	CcSEcCtD
Ifosfamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00018	0.000862	CcSEcCtD
Ifosfamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00018	0.000862	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000179	0.000861	CcSEcCtD
Ifosfamide—Dizziness—Prednisolone—ankylosing spondylitis	0.000179	0.00086	CcSEcCtD
Ifosfamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000179	0.000858	CcSEcCtD
Ifosfamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000179	0.000858	CcSEcCtD
Ifosfamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000179	0.000858	CcSEcCtD
Ifosfamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000179	0.000858	CcSEcCtD
Ifosfamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000179	0.000858	CcSEcCtD
Ifosfamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000178	0.000856	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000177	0.000849	CcSEcCtD
Ifosfamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000176	0.000846	CcSEcCtD
Ifosfamide—Cough—Methotrexate—ankylosing spondylitis	0.000176	0.000845	CcSEcCtD
Ifosfamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000176	0.000844	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—ankylosing spondylitis	0.000175	0.000839	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—ankylosing spondylitis	0.000172	0.000824	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000172	0.000824	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—ankylosing spondylitis	0.000172	0.000824	CcSEcCtD
Ifosfamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000171	0.000822	CcSEcCtD
Ifosfamide—Rash—Prednisolone—ankylosing spondylitis	0.000171	0.00082	CcSEcCtD
Ifosfamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000171	0.000819	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00017	0.000818	CcSEcCtD
Ifosfamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00017	0.000817	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—ankylosing spondylitis	0.00017	0.000815	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00017	0.000814	CcSEcCtD
Ifosfamide—Constipation—Prednisone—ankylosing spondylitis	0.000168	0.000808	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—ankylosing spondylitis	0.000166	0.000797	CcSEcCtD
Ifosfamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000165	0.000791	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000165	0.00079	CcSEcCtD
Ifosfamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000164	0.000789	CcSEcCtD
Ifosfamide—Infection—Methotrexate—ankylosing spondylitis	0.000163	0.000785	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000162	0.000779	CcSEcCtD
Ifosfamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000162	0.000779	CcSEcCtD
Ifosfamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000162	0.000779	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000161	0.000775	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000161	0.000773	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000161	0.000773	CcSEcCtD
Ifosfamide—Nausea—Prednisolone—ankylosing spondylitis	0.000161	0.000773	CcSEcCtD
Ifosfamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00016	0.000768	CcSEcCtD
Ifosfamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00016	0.000768	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00016	0.000767	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000159	0.000764	CcSEcCtD
Ifosfamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000158	0.000761	CcSEcCtD
Ifosfamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000158	0.000759	CcSEcCtD
Ifosfamide—Rash—Triamcinolone—ankylosing spondylitis	0.000157	0.000754	CcSEcCtD
Ifosfamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000157	0.000754	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000157	0.000753	CcSEcCtD
Ifosfamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000157	0.000753	CcSEcCtD
Ifosfamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000157	0.000752	CcSEcCtD
Ifosfamide—Urticaria—Prednisone—ankylosing spondylitis	0.000156	0.000751	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000156	0.000747	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000156	0.000747	CcSEcCtD
Ifosfamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000155	0.000743	CcSEcCtD
Ifosfamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000155	0.000743	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—ankylosing spondylitis	0.000154	0.000738	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00015	0.00072	CcSEcCtD
Ifosfamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00015	0.000718	CcSEcCtD
Ifosfamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00015	0.000718	CcSEcCtD
Ifosfamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000148	0.000711	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000148	0.000709	CcSEcCtD
Ifosfamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000148	0.000709	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000147	0.000704	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000146	0.000702	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000145	0.000696	CcSEcCtD
Ifosfamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000144	0.00069	CcSEcCtD
Ifosfamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000144	0.00069	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000143	0.000687	CcSEcCtD
Ifosfamide—Rash—Dexamethasone—ankylosing spondylitis	0.000143	0.000684	CcSEcCtD
Ifosfamide—Rash—Betamethasone—ankylosing spondylitis	0.000143	0.000684	CcSEcCtD
Ifosfamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000142	0.000684	CcSEcCtD
Ifosfamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000142	0.000684	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000142	0.000682	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000142	0.000681	CcSEcCtD
Ifosfamide—Asthenia—Prednisone—ankylosing spondylitis	0.000141	0.000678	CcSEcCtD
Ifosfamide—Pain—Methotrexate—ankylosing spondylitis	0.000141	0.000676	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—ankylosing spondylitis	0.000139	0.000669	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000136	0.000651	CcSEcCtD
Ifosfamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000135	0.000647	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000135	0.000646	CcSEcCtD
Ifosfamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000134	0.000645	CcSEcCtD
Ifosfamide—Nausea—Betamethasone—ankylosing spondylitis	0.000134	0.000645	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000131	0.000628	CcSEcCtD
Ifosfamide—Dizziness—Prednisone—ankylosing spondylitis	0.00013	0.000625	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00013	0.000625	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00013	0.000625	CcSEcCtD
Ifosfamide—Vomiting—Prednisone—ankylosing spondylitis	0.000125	0.000601	CcSEcCtD
Ifosfamide—Rash—Prednisone—ankylosing spondylitis	0.000124	0.000596	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000124	0.000595	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000121	0.000582	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000118	0.000567	CcSEcCtD
Ifosfamide—Nausea—Prednisone—ankylosing spondylitis	0.000117	0.000561	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000116	0.000559	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000113	0.000541	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000109	0.000522	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000105	0.000502	CcSEcCtD
Ifosfamide—Rash—Methotrexate—ankylosing spondylitis	0.000104	0.000498	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000104	0.000498	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—ankylosing spondylitis	9.77e-05	0.000469	CcSEcCtD
